India Tops China in Big Pharma-Generic Deals: Merck Signs up with Sun Pharma

Merck, known as Merck, Sharp and Dohme in most of the ex-US world, will partner with Sun Pharma of India in a venture aimed at “innovative branded generics.” Sun will both develop and manufacture the drugs. Merck will help Sun with clinical development, registration and marketing. Companies like Pfizer and GlaxoSmithKline have already entered into drug supply deals with the major Indian generic drug companies. More details.... Stock Symbols: (NYSE: MRK) (BY: 524715) (PFE) (GSK) Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});